Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumoursCiro Celsa, Fable Zustovich, Naoshi Nishida et al.|Journal of Hepatology|2023Cited by 62
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in ItalyValentina Burgio, Andrea Casadei‐Gardini, Massimo Iavarone et al.|Cancer Management and Research|2021Cited by 38
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B DysfunctionClaudia Angela Maria Fulgenzi, Calogero Cammà, Bernhard Scheiner et al.|JAMA Oncology|2024Cited by 37